Monthly Cost Breakdown: Wegovy vs Mounjaro Conversion
Wegovy to Mounjaro Conversion Chart: Understanding Monthly Cost Differences
When comparing Wegovy to Mounjaro for weight management, the monthly cost structure varies significantly between these two prescription-only medicines. Wegovy follows a 16-week dose escalation schedule starting at 0.25mg (£79.99) and reaching maintenance at 2.4mg (£209.99), while Mounjaro escalates over 12 weeks to a maintenance dose of either 10mg or 15mg. The conversion chart between these medications isn't direct dose-to-dose, as they contain different active ingredients with distinct mechanisms of action. Understanding these cost differences helps you budget effectively for your long-term weight management journey.
The Wegovy to Mounjaro conversion chart reveals important considerations beyond just monthly costs. Wegovy's semaglutide works solely on GLP-1 receptors, while Mounjaro's tirzepatide targets both GIP and GLP-1 receptors as a dual agonist. This fundamental difference means that switching between them requires careful clinical assessment rather than simple dose conversion. Both medications must be prescribed alongside a reduced-calorie diet and increased physical activity, making the total monthly investment in your health programme an important factor when reviewing the conversion chart options.
Complete Monthly Pricing Breakdown for Wegovy to Mounjaro Conversion Chart
The Wegovy to Mounjaro conversion chart monthly costs at EverydayMeds start with our escalation pricing: 0.25mg at £79.99 (weeks 1-4), 0.5mg at £94.99 (weeks 5-8), 1mg at £99.99 (weeks 9-12), 1.7mg at £139.99 (weeks 13-16), and maintenance 2.4mg at £209.99 monthly. New customers apply code FIRST40 at checkout to reach these prices, while returning customers use DOSE25 for ongoing savings. Our bundle options provide convenient multi-month supply, such as the Ultimate Stability Trio offering three months of 2.4mg maintenance doses for £649.99. This pricing transparency helps you plan your annual weight management budget effectively.
When reviewing the Wegovy to Mounjaro conversion chart for cost planning, consider that Wegovy's annual maintenance cost at 2.4mg totals approximately £2,520 across 12 months. The 16-week escalation phase costs £515.97 total, followed by consistent monthly maintenance costs. Our GPhC-registered pharmacy (#9012878) ensures reliable supply with temperature-controlled next-day delivery, eliminating the risk of treatment interruption. Both discount codes automatically apply the maximum available savings, making the conversion chart pricing straightforward and predictable for long-term budgeting purposes.
Clinical Evidence Supporting Wegovy to Mounjaro Conversion Chart Decisions
The Wegovy to Mounjaro conversion chart should be informed by robust clinical evidence from their respective trial programmes. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), while STEP 5 demonstrated sustained clinically studied weight loss at 2 years. The SELECT trial also showed a 20% reduction in major cardiovascular events, adding important health outcomes beyond weight management to the conversion chart considerations.
When evaluating the Wegovy to Mounjaro conversion chart, it's important to note that these medications were studied in different trial populations with varying endpoints, making direct comparison inappropriate. Both prescription-only medicines have demonstrated significant efficacy in their respective clinical programmes, and the choice between them should be based on individual patient factors rather than head-to-head trial comparisons. Your prescriber can review your medical history and treatment goals to determine which option may be most suitable from the conversion chart possibilities.
How Wegovy Works in the Conversion Chart Context
Understanding Wegovy's mechanism of action is essential when reviewing any Wegovy to Mounjaro conversion chart. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This medication works on brain appetite centres to reduce hunger signals and promote feelings of satiety after smaller meals, potentially reducing food cravings throughout the day. The once-weekly FlexTouch pen delivery system maintains consistent medication levels, supporting sustained appetite regulation across the seven-day dosing interval. Unlike medications that work peripherally, Wegovy's central nervous system activity on hypothalamic appetite control centres provides a physiological approach to weight management that must be combined with lifestyle modifications for optimal results.
Ordering Process for Wegovy Through Our Conversion Chart Service
Accessing Wegovy through our Wegovy to Mounjaro conversion chart service begins with a comprehensive 3-minute online clinical assessment that reviews your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service) to determine suitability for either Wegovy or Mounjaro based on your individual circumstances. Once approved, we provide next-day delivery using cold-chain temperature-controlled packaging to ensure medication integrity from our GPhC-registered pharmacy (#9012878). The entire process is designed for convenience while maintaining the highest clinical and pharmaceutical standards. This streamlined approach means you can begin your chosen treatment from the conversion chart options quickly and safely, with ongoing support from our clinical team throughout your weight management journey.
Storage and Practical Considerations in the Wegovy to Mounjaro Conversion Chart
The Wegovy to Mounjaro conversion chart includes important practical differences, particularly around storage requirements that may influence your choice. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability provides greater convenience for travel, work schedules, or lifestyle flexibility. The FlexTouch pen system delivers precise doses through the 16-week escalation schedule, with clear dose markings and an audible click confirmation for each weekly injection. This practical advantage often influences patient preference when reviewing conversion chart options, as the storage flexibility can significantly impact treatment adherence and lifestyle compatibility.
Monthly Cost Planning Strategy for Wegovy to Mounjaro Conversion Chart Users
Effective monthly cost planning using our Wegovy to Mounjaro conversion chart requires understanding both the escalation phase expenses and long-term maintenance budgeting. The first four months of Wegovy total £515.97, followed by consistent £209.99 monthly costs that allow for precise annual budgeting of £2,520 for maintenance therapy. Our bundle options provide cost-effective alternatives for patients who prefer fewer transactions, with the Consistency 2.4mg bundle offering two months' supply for £419.99. Strategic use of our discount codes – FIRST40 for new patients and DOSE25 for returning customers – ensures maximum value throughout your treatment journey.
Long-term financial planning with the Wegovy to Mounjaro conversion chart should also consider the potential for insurance coverage or health savings account eligibility, as weight management medications may qualify for reimbursement under certain circumstances. Our team provides detailed receipts and prescription documentation to support any insurance claims or flexible spending account submissions. The predictable monthly costs eliminate budget uncertainty, allowing you to plan effectively for this important health investment while maintaining financial stability throughout your weight management programme.
Making Your Final Decision: Wegovy to Mounjaro Conversion Chart Guidance
Your decision using our Wegovy to Mounjaro conversion chart should balance monthly costs with clinical suitability, storage convenience, and personal treatment preferences. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which is right for you based on your medical history, previous treatment responses, and lifestyle factors. The conversion chart provides cost transparency, but your individual response to GLP-1 versus dual GIP/GLP-1 receptor modulation may ultimately guide the optimal choice. Consider scheduling a consultation with our clinical team to review your specific circumstances against both options in the conversion chart. Remember that successful weight management with either medication requires commitment to the prescribed lifestyle modifications alongside the monthly medication investment, making both the clinical and financial aspects equally important in your decision-making process.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
